Xvivo Perfusion AB (publ) (STO:XVIVO)

Xvivo Perfusion AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,969	15,403	10,379	5,459	8,215	9,018
Market Cap Growth	-62.48%	48.41%	90.12%	-33.55%	-8.90%	99.42%
Enterprise Value	5,814	14,978	9,810	5,150	7,936	8,417
Last Close Price	189.50	489.00	329.50	183.00	278.50	314.00
PE Ratio	199.63	89.46	113.04	296.26	1007.78	-
Forward PE	52.31	92.61	199.34	111.93	211.39	288.07
PS Ratio	7.34	18.73	17.37	13.15	31.80	50.14
PB Ratio	2.85	7.14	5.34	3.82	6.39	8.94
P/TBV Ratio	4.17	10.81	7.84	6.86	10.06	11.59
P/FCF Ratio	-	379.77	3172.09	564.50	-	-
P/OCF Ratio	78.31	138.41	224.23	195.98	-	-
EV/Sales Ratio	7.15	18.21	16.42	12.40	30.71	46.80
EV/EBITDA Ratio	42.12	135.06	515.41	387.15	-	-
EV/EBIT Ratio	85.41	167.53	1818.08	1156.32	-	-
EV/FCF Ratio	-241.14	369.29	2998.27	532.54	-	-
Debt / Equity Ratio	0.06	0.02	0.02	0.01	0.00	0.01
Debt / EBITDA Ratio	0.90	0.28	1.06	0.51	-	-
Debt / FCF Ratio	-	0.84	9.61	1.03	-	-
Asset Turnover	0.35	0.36	0.30	0.25	0.19	0.20
Inventory Turnover	0.86	1.12	1.23	1.29	1.02	0.97
Quick Ratio	3.27	3.14	4.94	2.60	4.43	5.51
Current Ratio	5.41	4.58	6.15	3.47	5.24	6.41
Return on Equity (ROE)	1.43%	8.39%	5.44%	1.36%	0.71%	-5.51%
Return on Assets (ROA)	1.83%	2.43%	0.17%	0.17%	-0.87%	-3.09%
Return on Capital (ROIC)	1.97%	2.68%	0.20%	0.20%	-1.02%	-3.45%
Return on Capital Employed (ROCE)	3.00%	4.00%	0.30%	0.30%	-	-
Earnings Yield	0.50%	1.12%	0.89%	0.34%	0.10%	-0.48%
FCF Yield	-0.40%	0.26%	0.03%	0.18%	-0.27%	-0.17%
Buyback Yield / Dilution	-1.25%	-5.73%	-1.39%	-2.04%	-6.49%	-1.39%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.